Dietary Interventions in Prediabetes

Sponsor
Mayo Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT01729078
Collaborator
(none)
48
1
3
16
3

Study Details

Study Description

Brief Summary

Assessment of glucose metabolism and liver fat after 12 week dietary intervention in pre diabetes subjects. Subjects will be randomized to either high fat (olive oil supplemented),high carb/high fiber (beans supplemented) and high carb/low fiber diets. Glucose metabolism will be assessed by labeled oral glucose tolerance test and liver fat by magnetic resonance spectroscopy pre randomization and at 8 and 12 week after starting dietary intervention.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Dietary intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Basic Science
Official Title:
The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Feb 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: high fat ( MUFA) diet

intervention using high fat diet.

Dietary Supplement: Dietary intervention
three different diets ( high fat-low carb-low fiber/high carb-low fat - high fiber/high carb-low fat-low fiber)

Experimental: high carb/high fiber

diet using high carb-high fiber with dry beans

Dietary Supplement: Dietary intervention
three different diets ( high fat-low carb-low fiber/high carb-low fat - high fiber/high carb-low fat-low fiber)

Experimental: high carb/low fat

Habitual diet

Dietary Supplement: Dietary intervention
three different diets ( high fat-low carb-low fiber/high carb-low fat - high fiber/high carb-low fat-low fiber)

Outcome Measures

Primary Outcome Measures

  1. Changes in liver fat content after 12 weeks of intervention [12 weeks]

Secondary Outcome Measures

  1. Change in glucose metabolism after 12 weeks of intervention [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Impaired fasting glucose(100-125 mg/dl)

  • HbA1c 5.7-6.4 %

  • BMI 26-40 kg/sq.m

Exclusion Criteria:
  • MRS contraindication

  • Pregnant women

  • Liver disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo clinic Rochester Minnesota United States 55901

Sponsors and Collaborators

  • Mayo Clinic

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rita Basu, PI, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01729078
Other Study ID Numbers:
  • 12-003216
First Posted:
Nov 20, 2012
Last Update Posted:
Jul 29, 2015
Last Verified:
Jul 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2015